In a groundbreaking milestone for psychedelics in Europe, a cross-party MEP Action Group for the Medical Use of Psychedelics was launched at an expert roundtable on...
A UK Parliamentary debate on 18 May saw crossparty calls to conduct an urgent review of the evidence for psilocybin’s current status as a Schedule 1...
With a rise in clinical research and trials into the use of psychedelic therapies for mental health, and with a number of countries changing regulations around...
Psychedelics work by altering neural networks in our brains – this first-of-its-kind partnership between Clerkenwell Health and MYndspan will help understand this link definitively, and provide...
A new study has investigated whether psilocybin could be the key to restore ‘fear extinction’ and thus help treat post-traumatic stress disorder (PTSD).
Psychedelics and creativity have been linked in anecdotal evidence from artists, scientists, actors, entertainers and musicians.
The world’s first postgraduate course on psychedelics has been launched at the University of Exeter – an interdisciplinary programme for healthcare workers, therapists and others to...
Filament Health and PharmAla Biotech Holdings Inc.
In 1943, Swiss chemist Albert Hofmann took the first LSD trip.
With a high demand for psychedelic facilitators, Cybin Inc.